Aides in Respiration Health Coaching for COPD



Status:Active, not recruiting
Conditions:Chronic Obstructive Pulmonary Disease, Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:40 - 95
Updated:6/3/2016
Start Date:November 2014
End Date:July 2017

Use our guide to learn which trials are right for you!

Health Coaching to Reduce Disparities for Patients With Chronic Obstructive Pulmonary Disease (COPD)

This proposed study will examine whether health coaches can improve the management of COPD
in a population of vulnerable patients cared for in 'safety-net' clinics. The study is
designed as a randomized controlled trial for patients with moderate to severe COPD.
Patients will be randomized into a health coaching group and a usual care group. Those in
the health coaching group will receive 9 months of active health coaching. Outcome variables
will be measured at baseline and after 9 months

None as would duplicate information recorded elsewhere

Inclusion Criteria:

- Patient at one of the participating primary care clinics (at least 1 visit in past 12
months)

- Age 40 and older

- Speaking English or Spanish

- Plan to continue to be seen at current clinic and to not leave the area for >2 months
anytime in the next 9 months or to be absent at 9 or 15 months

- COPD defined as ever having had a post-bronchodilator Forced Expiratory Volume in 1
second/Forced Vital Capacity (FEV1/FVC) <.70

- Willingness to attempt spirometry

- At least moderate COPD, defined as at least one of the following:

- Ever Forced Expiratory Volume in 1 second (FEV1) < 80% predicted

- 1 or more emergency department (ED) visit for COPD exacerbation in past 12
months

- 1 or more hospital stays for COPD exacerbation in past 12 months

- 1 or more prescriptions for oral prednisone for at least 40 mg per day for at
least 5 days in past 12 months

- Ever on home oxygen therapy

- Ever outpatient percutaneous oxygen saturation of
- Ever outpatient partial pressure of oxygen (ppO2) by arterial blood gas (ABG) of

- At least 3 outpatient visits for COPD in past 12 months AND a current COPD
Assessment Test (CAT) score of >/=10 or an modified Medical Research Council
(mMRC) score of >/=2.

- Currently using tiotropium inhaler or combination inhaled corticosteroid and
long-acting beta agonist

Exclusion Criteria:

- Unable to participate in the study due to mental or physical impairment

- Severe or terminal illness that precludes focus on COPD

- No phone
We found this trial at
1
site
San Francisco, California 94110
Principal Investigator: David H Thom, MD, PhD
Phone: 415-206-6167
?
mi
from
San Francisco, CA
Click here to add this to my saved trials